Cited by 602HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.

Open access

Liu, Albert Y., Cohen, Stephanie E., Vittinghoff, Eric, Anderson, Peter L., Doblecki-Lewis, Susanne, Bacon, Oliver, Chege, Wairimu, Postle, Brian S., Matheson, Tim, Amico, K. Rivet, Liegler, Teri, Rawlings, M. Keith, Trainor, Nikole, Blue, Robert Wilder, Estrada, Yannine, Coleman, Megan E., Cardenas, Gabriel, Feaster, Daniel J., Grant, Robert, Philip, Susan S., Elion, Richard, Buchbinder, Susan, Kolber, Michael A.·2016·JAMA Internal Medicine

DOI 10.1001/jamainternmed.2015.4683PMC PMC5042323

Open this paper in CoChat — free account Open PDF

Abstract

IMPORTANCE: Several randomized clinical trials have demonstrated the efficacy of preexposure prophylaxis (PrEP) in preventing human immunodeficiency virus (HIV) acquisition. Little is known about adherence to the regimen, sexual practices, and overall effectiveness when PrEP is implemented in clinics that treat sexually transmitted infections (STIs) and community-based clinics serving men who have sex with men (MSM). OBJECTIVE: To assess PrEP adherence, sexual behaviors, and the incidence of STIs and HIV infection in a cohort of MSM and transgender women initiating PrEP in the United States. DESIGN, SETTING, AND PARTICIPANTS: Demonstration project conducted from October 1, 2012, through February 10, 2015 (last date of follow-up), among 557 MSM and transgender women in 2 STI clinics in San Francisco, California, and Miami, Florida, and a community health center in Washington, DC. Data were analyzed from December 18, 2014, through August 8, 2015. INTERVENTIONS: A combination of daily, oral tenofovir disoproxil fumarate and emtricitabine was provided free of charge for 48 weeks. All participants received HIV testing, brief client-centered counseling, and clinical monitoring. MAIN OUTCOMES AND MEASURES: Concentrations of tenofovir diphosphate in dried blood spot samples, self-reported numbers of anal sex partners and episodes of condomless receptive anal sex, and incidence of STI and HIV acquisition. RESULTS: Overall, 557 participants initiated PrEP, and 437 of these (78.5%) were retained through 48 weeks. Based on the findings from the 294 participants who underwent measurement of tenofovir diphosphate levels, 80.0% to 85.6% had protective levels (consistent with ≥4 doses/wk) at follow-up visits. African American participants (56.8% of visits; P = .003) and those from the Miami site (65.1% of visits; P < .001) were less likely to have protective levels, whereas those with stable housing (86.8%; P = .02) and those reporting at least 2 condomless anal sex partners in the past 3 months (88.6%; P = .01) were more likely to have protective levels. The mean number of anal sex partners declined during follow-up from 10.9 to 9.3, whereas the proportion engaging in condomless receptive anal sex remained stable at 65.5% to 65.6%. Overall STI incidence was high (90 per 100 person-years) but did not increase over time. Two individuals became HIV infected during follow-up (HIV incidence, 0.43 [95% CI, 0.05-1.54] infections per 100 person-years); both had tenofovir diphosphate levels consistent with fewer than 2 doses/wk at seroconversion. CONCLUSIONS AND RELEVANCE: The incidence of HIV acquisition was extremely low despite a high incidence of STIs in a large US PrEP demonstration project. Adherence was higher among those participants who reported more risk behaviors. Interventions that address racial and geographic disparities and housing instability may increase the impact of PrEP.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2015.4683

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291
The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000093487.78664.3c · Cited by 6,359
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Self-citation
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
Preexposure Prophylaxis for HIV Infection among African Women
Damme, L. V., Corneli, A. L., Ahmed, K., Agot, K. E., Lombaard, J. J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R. N., Onyango, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202614 · Cited by 1,633
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., Hosek, S., Mosquera, C., Casapía, M., Montoya, O., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70847-3 · Cited by 1,229
Regression models for ordinal responses: a review of methods and applications
Ananth, C. V. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.6.1323 · Cited by 594
Diagnoses of HIV infection in the United States and dependent areas, 2012
Siddiqi, A.-E.-A., Cohen, S. M., Johnson, A. S., Hu, X., Li, J., Patala, A., Wu, B., Guo, X., Dasari, S. R., Hall, I., et al. (2014) · Cited by 429

Show all 46 references

Research works printed but not linked: 6

[4]McCormack S Dunn D Pragmatic Open-Label Randomised Trial of Preexposure Prophylaxis: The PROUD Study [Abstract 22LB] Conference on Retroviruses and Opportunistic Infections (CROI) Seattle, WA February 23-26, 2015
[5]Molina JM Capitant C Spire B On Demand PrEP With Oral TDF-FTC in MSM: Results of the ANRS Ipergay Trial [Abstract 24LB] Conference on Retroviruses and Opportunistic Infections (CROI) Seattle, WA February 23-26, 2015 2015
[40]Liu A Developing and Implementing a Mobile Health (mHealth) Adherence Support System for HIV-Uninfected Men who have Sex with Men (MSM) Taking Pre-Exposure Prophylaxis (PrEP): The iText Study 8th International Conference on HIV Treatment and Prevention Adherence; [AB 229] Miami, FL June 2-4, 2013
[42]Scott H Vittinghoff E Irvin R Sex Pro: A Personalized HIV Risk Assessment Tool for Men Who Have Sex With Men [Abstract 1017] Conference on Retroviruses and Opportunistic Infections (CROI) Seattle, WA February 23-26, 2015
[43]Vallabhaneni S Hartogensis W Sheon N Harnessing mobile health technology in HIV research: a pilot study utilizing a smartphone-based daily-diary app to collect event-level sexual activity data [Abstract TUPE358] 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention 2013 Kuala Lampur, Malaysia
[46]Cohen SE Vittinghoff E Doblecki-Lewis S Response to “Race and the public health impact potential of PrEP in the United States” J Acquir Immune Defic Syndr 2015 PMC4558271 26049284

Sorted by citations

Items 101–200 of 599

“Support Your Client at the Space That They're in”: HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation
Calabrese, S. K., Magnus, M., Mayer, K. H., Krakower, D., Eldahan, A. I., Hawkins, L. A. G., Underhill, K., Hansen, N. B., Kershaw, T., Betancourt, J. R., et al. (2017) · AIDS Patient Care and STDs · doi:10.1089/apc.2017.0002 · Cited by 68
The Intersection of HIV and Syphilis: Update on the Key Considerations in Testing and Management
Ren, M., Dashwood, T., & Walmsley, S. L. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00564-z · Cited by 79
Preexposure Prophylaxis to Prevent Acquisition of HIV
US Preventive Services Task Force, Barry, M. J., Nicholson, W. K., Silverstein, M., Chelmow, D. P., Coker, T. R., Davis, E. M., Donahue, K. E., Jaén, C. R., Kubik, M., et al. (2023) · JAMA · doi:10.1001/jama.2023.14461 · Cited by 70
Testing the Efficacy of a Social Networking Gamification App to Improve Pre-Exposure Prophylaxis Adherence (P3: Prepared, Protected, emPowered): Protocol for a Randomized Controlled Trial
LeGrand, S., Knudtson, K., Benkeser, D. C., Muessig, K. E., Mcgee, A., Sullivan, P. S., & Hightow‐Weidman, L. (2018) · JMIR Research Protocols · doi:10.2196/10448 · Cited by 68
Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa
Stranix‐Chibanda, L., Anderson, P. L., Kacanek, D., Hosek, S., Huang, S., Nematadzira, T., Taulo, F., Korutaro, V., Nakabiito, C., Masenya, M., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1872 · Cited by 67
The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices
LeVasseur, M. T., Goldstein, N. D., Tabb, L. P., Olivieri‐Mui, B. L., & Welles, S. L. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001555 · Cited by 68
Skating on thin ice: stimulant use and sub‐optimal adherence to HIV pre‐exposure prophylaxis
Hojilla, J. C., Vlahov, D., Glidden, D. V., Amico, K. R., Mehrotra, M., Hance, R. J., Grant, R. M., & Carrico, A. W. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25103 · Cited by 67
Distance to clinic is a barrier to Pr EP uptake and visit attendance in a community in rural Uganda
Mayer, C., Owaraganise, A., Kabami, J., Kwarisiima, D., Koss, C. A., Charlebois, E. D., Kamya, M. R., Petersen, M. L., Havlir, D. V., & Jewell, B. L. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25276 · Cited by 66
Efficacy and Safety of Oral TDF-Based Pre-exposure Prophylaxis for Men Who Have Sex With Men: A Systematic Review and Meta-Analysis
Huang, X., Hou, J., Song, A., Liu, X., Yang, X., Xu, J., Zhang, J., Hu, Q., Chen, H., Chen, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00799 · Cited by 67
Facilitators and Barriers of Pre-exposure Prophylaxis (PrEP) Uptake Among Rural Men who have Sex with Men Living in the Midwestern U.S.
Owens, C., Hubach, R. D., Williams, D. M., Voorheis, E., Lester, J. N., Reece, M., & Dodge, B. (2020) · Archives of Sexual Behavior · doi:10.1007/s10508-020-01654-6 · Cited by 63
Correction: Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection – A meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis
Werner, R. N., Gaskins, M. D., Nast, A., & Dressler, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226209 · Cited by 66
Long‐term retention in pre‐exposure prophylaxis care among men who have sex with men and transgender women in the United States
Chan, P. A., Patel, R. R., Mena, L. A., Marshall, B. D. L., Rose, J. S., Coats, C. S., Montgomery, M. C., Tao, J., Sosnowy, C. D., Mayer, K. H., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25385 · Cited by 64
Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries
Hoornenborg, E., Krakower, D., Prins, M., & Mayer, K. H. (2017) · AIDS · doi:10.1097/qad.0000000000001627 · Cited by 61
Ending the HIV epidemic in the USA: an economic modelling study in six cities
Nosyk, B., Zang, X., Krebs, E., Enns, B., Min, J., Behrends, C. N., Rio, C. D., Dombrowski, J., Feaster, D., Golden, M., et al. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(20)30033-3 · Cited by 61
Getting to Zero San Francisco: A Collective Impact Approach
Buchbinder, S., & Havlir, D. V. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002200 · Cited by 62
Factors associated with PrEP awareness according to age and willingness to use HIV prevention technologies: the 2017 online survey among MSM in Brazil
Torres, T. S., Luz, P. M., Boni, R. B. D., de Vasconcellos, M. T. L., Hoagland, B., Garner, A., Moreira, R. I., Veloso, V. G., & Grinsztejn, B. G. J. (2019) · AIDS Care · doi:10.1080/09540121.2019.1619665 · Cited by 60
PrEP uptake and adherence in relation to HIV-1 incidence among Kenyan men who have sex with men
Wahome, E., Graham, S. M., Thiong’o, A. N., Mohamed, K., Oduor, T., Gichuru, E., Mwambi, J., Prins, M., van der Elst, E., & Sanders, E. J. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100541 · Cited by 62
Should I Convince My Partner to Go on Pre-Exposure Prophylaxis (PrEP)? The Role of Personal and Relationship Factors on PrEP-Related Social Control among Gay and Bisexual Men
John, S. A., Starks, T. J., Rendina, H. J., Grov, C., & Parsons, J. T. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1835-1 · Cited by 60
Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies
Rutstein, S. E., Smith, D. K., Dalal, S., Baggaley, R. C., & Cohen, M. S. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(20)30203-4 · Cited by 68
Does pre‐exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review
Freeborn, K., & Portillo, C. J. (2017) · Journal of Clinical Nursing · doi:10.1111/jocn.13990 · Cited by 68
Knowledge, interest, and anticipated barriers of pre-exposure prophylaxis uptake and adherence among gay, bisexual, and men who have sex with men who are incarcerated
Brinkley‐Rubinstein, L., Peterson, M., Arnold, T. L., Nunn, A. S., Beckwith, C. G., Castonguay, B. J. U., Junious, E., Lewis, C., & Chan, P. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205593 · Cited by 57
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study
Yager, J., Castillo‐Mancilla, J., Ibrahim, M. E., Brooks, K. M., McHugh, C., Morrow, M., McCallister, S. H., Bushman, L. R., MaWhinney, S., Kiser, J. J., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002354 · Cited by 60
Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study
Grant, R. M., Mannheimer, S., Hughes, J. P., Hirsch‐Moverman, Y., Loquere, A., Chitwarakorn, A., Curlin, M. E., Li, M., Amico, K. R., Hendrix, C. W., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1086 · Cited by 60
Is on-Demand HIV Pre-exposure Prophylaxis a Suitable Tool for Men Who Have Sex With Men Who Practice Chemsex? Results From a Substudy of the ANRS-IPERGAY Trial
Roux, P., Fressard, L., Suzan, M., Chas, J., Sagaon‐Teyssier, L., Capitant, C., Meyer, L., Tremblay, C. L., Castro, D. R., Pialoux, G., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001781 · Cited by 58
Clinical exigencies, psychosocial realities: negotiating HIV pre‐exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada
Newman, P. A., Guţă, A., Lacombe‐Duncan, A., & Tepjan, S. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25211 · Cited by 57
Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations
Koss, C. A., Bacchetti, P., Hillier, S. L., Livant, E., Horng, H., Mgodi, N. M., Mirembe, B. G., Gomez, K., Horn, S., Liu, A., et al. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0202 · Cited by 58
Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen
Gandhi, M., Murnane, P. M., Bacchetti, P., Elion, R., Kolber, M. A., Cohen, S. E., Horng, H., Louie, A., Kuncze, K., Koss, C. A., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001615 · Cited by 56
Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study
Marins, L. M. S., Torres, T. S., Leite, I. D. C., Moreira, R. I., Luz, P. M., Hoagland, B., Kallas, E. G., Madruga, J. V., Liu, A., Anderson, P. L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221281 · Cited by 57
Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report
Cohen, S. E., Sachdev, D. D., Lee, S. A., Scheer, S., Bacon, O., Chen, M.-J., Okochi, H., Anderson, P. L., Kearney, M. F., Coffey, S., et al. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30288-1 · Cited by 53
Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial
Mitchell, J. T., LeGrand, S., Hightow‐Weidman, L., McKellar, M., Kashuba, A. D. M., Cottrell, M. L., McLaurin, T., Satapathy, G., & McClernon, F. J. (2018) · JMIR mhealth and uhealth · doi:10.2196/10456 · Cited by 54
Brief Report: Associations Between Self-Reported Substance Use Behaviors and PrEP Acceptance and Adherence Among Black MSM in the HPTN 073 Study
Okafor, C. N., Hucks‐Ortiz, C., Hightow‐Weidman, L., Magnus, M., Emel, L., Beauchamp, G. G., Kuo, I. C., Hendrix, C. W., Mayer, K. H., & SHOPTAW, S. J. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002407 · Cited by 58
MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication
Biello, K. B., Mimiaga, M. J., Santostefano, C. M., Novak, D. S., & Mayer, K. H. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1972-6 · Cited by 53
Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis
Noret, M., Balavoine, S., Pintado, C., Siguier, M., Brun, A., Bauer, R., Loze, B., Leplatois, A., Aslan, A., Moudachirou, K., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001939 · Cited by 56
Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the U.S.: A Narrative Review of the Literature
Baldwin, A., Light, B., & Allison, W. E. (2021) · Archives of Sexual Behavior · doi:10.1007/s10508-020-01903-8 · Cited by 59
PrEP Implementation and Persistence in a County Health Department Setting in Atlanta, GA
Rolle, C.-P., Onwubiko, U. N., Jo, J., Sheth, A. N., Kelley, C. F., & Holland, D. P. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02654-x · Cited by 53
HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment
Sullivan, A. K., Saunders, J., Desai, M., Cartier, A., Mitchell, H. D., Jaffer, S., Ogaz, D., Chiavenna, C., Charlett, A., Diamente, V., et al. (2023) · The Lancet HIV · doi:10.1016/s2352-3018(23)00256-4 · Cited by 63
HIV pre‐exposure prophylaxis for female sex workers: ensuring women’s family planning needs are not left behind
Bowring, A. L., Ampt, F. H., Schwartz, S., Stoove, M. A., Luchters, S. M. F., Baral, S., & Hellard, M. E. (2020) · Journal of the International AIDS Society · doi:10.1002/jia2.25442 · Cited by 49
Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study
Grant, R. M., Pellegrini, M., Defechereux, P. A., Anderson, P. L., Yu, M. A., Glidden, D. V., O’Neal, J. D., Yager, J., Bhasin, S., Sevelius, J. M., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1160 · Cited by 54
Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project
Tang, E. C., Vittinghoff, E., Anderson, P. L., Cohen, S. E., Doblecki‐Lewis, S., Bacon, O., Coleman, M. E., Buchbinder, S., Chege, W., Kolber, M. A., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001566 · Cited by 50
Two-Way Short Message Service (SMS) Communication May Increase Pre-Exposure Prophylaxis Continuation and Adherence Among Pregnant and Postpartum Women in Kenya
Pintye, J., Rogers, Z., Kinuthia, J., Mugwanya, K., Abuna, F., Lagat, H., Sila, J., Kemunto, V., Baeten, J., John-Stewart, G., et al. (2020) · Global Health: Science and Practice Journal · doi:10.9745/ghsp-d-19-00347 · Cited by 49
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018
Wright, E., Grulich, A. E., Roy, K., Boyd, M. A., Cornelisse, V. J., Russell, D. B., O’Donnell, D., Whittaker, B., Crooks, L., & Zablotska, I. (2018) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30260-0 · Cited by 51
Brief Report: Informing Strategies to Build PrEP Capacity Among San Francisco Bay Area Clinicians
Bacon, O., Gonzalez, R., Andrew, E. V. W., Potter, M. B., Iñiguez, J. R., Cohen, S. E., Liu, A., & Fuchs, J. D. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001182 · Cited by 49
Awareness, Willingness, and Use of Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Washington, DC and Miami-Dade County, FL: National HIV Behavioral Surveillance, 2011 and 2014
Patrick, R., Forrest, D. W., Cardenas, G. A., Opoku, J., Magnus, M., Phillips, G., Greenberg, A. E., Metsch, L. R., Kharfen, M., LaLota, M., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001414 · Cited by 50
Advancing the case for nurse practitioner‐based models to accelerate scale‐up of HIV pre‐exposure prophylaxis
Nelson, L. E., McMahon, J. M., Leblanc, N. M., Braksmajer, A., Crean, H. F., Smith, K., & Xue, Y. (2018) · Journal of Clinical Nursing · doi:10.1111/jocn.14675 · Cited by 51
Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation
Spinelli, M. A., & Buchbinder, S. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz896 · Cited by 49
University of North Carolina/Emory Center for Innovative Technology (iTech) for Addressing the HIV Epidemic Among Adolescents and Young Adults in the United States: Protocol and Rationale for Center Development
Hightow‐Weidman, L., Muessig, K. E., Rosenberg, E. S., Sanchez, T., LeGrand, S., Gravens, L., & Sullivan, P. S. (2018) · JMIR Research Protocols · doi:10.2196/10365 · Cited by 47
HIV preexposure prophylaxis for adolescents and young adults
Allen, E. B., Gordon, A. R., Krakower, D., & Hsu, K. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000512 · Cited by 48
Modeling an integrated HIV prevention and care continuum to achieve the Ending the HIV Epidemic goals
Jenness, S. M., Johnson, J. A., Hoover, K. W., Smith, D. K., & Delaney, K. P. (2020) · AIDS · doi:10.1097/qad.0000000000002681 · Cited by 48
Determinants of Pre-exposure Prophylaxis (PrEP) Implementation in Transgender Populations: A Qualitative Scoping Review
Zamantakis, A., Li, D. H., Benbow, N., Smith, J. D., & Mustanski, B. S. (2022) · AIDS and Behavior · doi:10.1007/s10461-022-03943-8 · Cited by 51
A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol
Chow, E. P. F., Walker, S. M., Hocking, J. S., Bradshaw, C. S., Chen, M. Y., Tabrizi, S. N., Howden, B. P., Law, M. G., Maddaford, K., Read, T. R. H., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2541-3 · Cited by 45
Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users
Shrestha, R., Karki, P., Altice, F. L., Dubov, O., Fraenkel, L., Huedo-Medina, T. B., & Copenhaver, M. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1851-1 · Cited by 46
Family planning providers' role in offering PrEP to women
Seidman, D. L., Weber, S., Carlson, K., & Witt, J. S. (2018) · Contraception · doi:10.1016/j.contraception.2018.01.007 · Cited by 46
Pre-exposure Prophylaxis Use and Medication Adherence Among Men Who Have Sex With Men
Maxwell, S., Gafos, M., & Shahmanesh, M. (2019) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000105 · Cited by 50
Oral preexposure prophylaxis continuation, measurement and reporting
Stankevitz, K., Grant, H., Lloyd, J., Gomez, G. B., Kripke, K. E., Torjesen, K., Ong, J. J., & Terris‐Prestholt, F. (2020) · AIDS · doi:10.1097/qad.0000000000002598 · Cited by 44
An Electronic Pre-Exposure Prophylaxis Initiation and Maintenance Home Care System for Nonurban Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial
Siegler, A. J., Brock, J. B., Hurt, C. B., Ahlschlager, L., Dominguez, K. D., Kelley, C. F., Jenness, S. M., Wilde, G., Jameson, S. B., Herring, G. B., et al. (2019) · JMIR Research Protocols · doi:10.2196/13982 · Cited by 45
“I wish to remain HIV negative”: Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya
Kimani, M., van der Elst, E., Chirro, O., Wahome, E., Ibrahim, F., Mukuria, N., de Wit, T. F. R., Graham, S. M., Operario, D., & Sanders, E. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244226 · Cited by 45
DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with Men
Liu, A., Laborde, N. D., Coleman, K., Vittinghoff, E., Gonzalez, R., Wilde, G., Thorne, A. L., Ikeguchi, E., Shafner, L., Sunshine, L., et al. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-03054-2 · Cited by 45
Primary Care Providers’ Knowledge, Attitudes, and Beliefs About HIV Pre-Exposure Prophylaxis (PrEP): Informing Network-Based Interventions
Storholm, E. D., Ober, A. J., Mizel, M. L., Matthews, L. J., Sargent, M. J., Todd, I., Zajdman, D., & Green, H. (2021) · AIDS Education and Prevention · doi:10.1521/aeap.2021.33.4.325 · Cited by 44
Engagement of Gay Men and Other Men Who Have Sex with Men (MSM) in the Response to HIV: A Critical Step in Achieving an AIDS-Free Generation
Stahlman, S. L., Beyrer, C., Sullivan, P. S., Mayer, K. H., & Baral, S. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1388-8 · Cited by 44
Outcomes of Preexposure Prophylaxis Referrals From Public STI Clinics and Implications for the Preexposure Prophylaxis Continuum
Bhatia, R., Modali, L., Lowther, M., Glick, N. R., Bell, M., Rowan, S. E., Keglovitz, K., & Schneider, J. A. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000690 · Cited by 44
Comparing Self-Report Pre-Exposure Prophylaxis Adherence Questions to Pharmacologic Measures of Recent and Cumulative Pre-Exposure Prophylaxis Exposure
Blumenthal, J. S., Pasipanodya, E. C., Jain, S., Sun, S., Ellorin, E. E., Morris, S., & Moore, D. J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00721 · Cited by 42
Maximizing the Benefits of HIV Preexposure Prophylaxis.
Buchbinder, S. (2018) · Europe PMC (PubMed Central) · Cited by 43
Exploring the Pre-exposure Prophylaxis (PrEP) Health Care Experiences Among Men Who Have Sex With Men (MSM) Who Live in Rural Areas of the Midwest
Owens, C., Hubach, R. D., Williams, D. M., Lester, J. N., Reece, M., & Dodge, B. (2020) · AIDS Education and Prevention · doi:10.1521/aeap.2020.32.1.51 · Cited by 43
Identifying and managing infectious disease syndemics in patients with HIV
Bromberg, D. J., Mayer, K. H., & Altice, F. L. (2020) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000631 · Cited by 45
Scaling up and out HIV prevention and behavioral health services to Latino sexual minority men in South Florida: multi-level implementation barriers, facilitators, and strategies
Harkness, A., Satyanarayana, S., Mayo, D., Smith-Alvarez, R., Rogers, B. G., Prado, G., & Safren, S. A. (2021) · AIDS Patient Care and STDs · doi:10.1089/apc.2021.0018 · Cited by 42
Self-reported race and ethnicity of US biobank participants compared to the US Census
Cohn, E. G., Hamilton, N. M., Larson, E., & Williams, J. K. (2017) · Journal of Community Genetics · doi:10.1007/s12687-017-0308-6 · Cited by 42
Individual HIV Risk versus Population Impact of Risk Compensation after HIV Preexposure Prophylaxis Initiation among Men Who Have Sex with Men
Jenness, S. M., Sharma, A., Goodreau, S. M., Rosenberg, E. S., Weiss, K. M., Hoover, K. W., Smith, D. K., & Sullivan, P. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169484 · Cited by 43
A Review of Approaches Used to Increase Awareness of Pre-exposure Prophylaxis (PrEP) in the United States
Sophus, A. I., & Mitchell, J. W. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2305-0 · Cited by 42
How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade Analysis
Fearon, E., Phillips, A. N., Mtetwa, S., Chabata, S. T., Mushati, P., Cambiano, V., Busza, J. R., Napierala, S., Hensen, B., Baral, S., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001980 · Cited by 42
Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis
Krebs, E., Enns, B., Wang, L., Zang, X., Panagiotoglou, D., del Rı́o, C., Dombrowski, J. C., Feaster, D. J., Golden, M. R., Granich, R., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217559 · Cited by 43
Changes in Familiarity with and Willingness to Take Preexposure Prophylaxis in a Longitudinal Study of Highly Sexually Active Gay and Bisexual Men
Grov, C., Rendina, H. J., Whitfield, T. H. F., Ventuneac, A., & Parsons, J. T. (2016) · LGBT Health · doi:10.1089/lgbt.2015.0123 · Cited by 40
PrEP in the Real World: Predictors of 6-Month Retention in a Diverse Urban Cohort
Lankowski, A. J., Bien-Gund, C. H., Patel, V. V., Felsen, U. R., Silvera, R. J., & Blackstock, O. J. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2296-x · Cited by 40
What are the motivations and barriers to pre-exposure prophylaxis (PrEP) use among black men who have sex with men aged 18–45 in London? Results from a qualitative study
Witzel, T. C., Nutland, W., & Bourne, A. H. (2019) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053773 · Cited by 40
Contrasting Self-Perceived Need and Guideline-Based Indication for HIV Pre-Exposure Prophylaxis Among Young, Black Men Who Have Sex with Men Offered Pre-Exposure Prophylaxis in Atlanta, Georgia
Lockard, A., Rosenberg, E. S., Sullivan, P. S., Kelley, C. F., Serota, D. P., Rolle, C.-P., Luisi, N., Pingel, E. S., & Siegler, A. J. (2019) · AIDS Patient Care and STDs · doi:10.1089/apc.2018.0135 · Cited by 40
Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis
Grant, R. M., Sevelius, J. M., Guanira, J. V., Aguilar, J. V., Chariyalertsak, S., & Deutsch, M. B. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001090 · Cited by 43
Protocol for an HIV Pre-exposure Prophylaxis (PrEP) Population Level Intervention Study in Victoria Australia: The PrEPX Study
Ryan, K. E., Mak, A., Stoove, M. A., Price, B., Fairley, C. K., Ruth, S., Lal, L., Asselin, J., El‐Hayek, C., Nguyen, L., et al. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00151 · Cited by 39
Body/Selves and Beyond: Men’s Narratives of Sexual Behavior on PrEP
Hughes, S. D., Sheon, N. M., Andrew, E. V. W., Cohen, S. E., Doblecki‐Lewis, S., & Liu, A. (2017) · Medical Anthropology · doi:10.1080/01459740.2017.1416608 · Cited by 38
Using preexposure prophylaxis, losing condoms? Preexposure prophylaxis promotion may undermine safe sex
Alaei, K., Paynter, C. A., Juan, S.-C., & Alaei, A. (2016) · AIDS · doi:10.1097/qad.0000000000001262 · Cited by 38
Acceptability of Injectable and On-Demand Pre-Exposure Prophylaxis Among an Online Sample of Young Men Who Have Sex with Men in California
Beymer, M. R., Gildner, J. L., Holloway, I. W., & Landovitz, R. J. (2018) · LGBT Health · doi:10.1089/lgbt.2017.0244 · Cited by 38
Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project
Spinelli, M. A., Glidden, D. V., Rodrigues, W. C., Wang, G., Vincent, M., Okochi, H., Kuncze, K., Mehrotra, M., Defechereux, P. A., Buchbinder, S., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002135 · Cited by 38
Leveraging Modularity During Replication of High-Fidelity Models: Lessons from Replicating an Agent-Based Model for HIV Prevention
Vermeer, W., Hjorth, A., Jenness, S. M., Brown, C. H., & Wilensky, U. J. (2020) · Journal of Artificial Societies and Social Simulation · doi:10.18564/jasss.4352 · Cited by 38
Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM.
Lockart, I., Matthews, G. V., & Danta, M. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000515 · Cited by 37
Willingness to use pre-exposure prophylaxis among Black and White men who have sex with men in Atlanta, Georgia
Rolle, C.-P., Rosenberg, E. S., Luisi, N., Grey, J. A., Sanchez, T., del Rı́o, C., Peterson, J. L., Frew, P. M., Sullivan, P. S., & Kelley, C. F. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462416675095 · Cited by 37
Implementation of pre‐exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy
Cáceres, C. F., Bórquez, A., Klausner, J. D., Baggaley, R. C., & Beyrer, C. (2016) · Journal of the International AIDS Society · doi:10.7448/ias.19.7.21108 · Cited by 37
Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol
Sharma, M., Chris, A., Chan, A., Knox, D. C., Wilton, J., McEwen, O., Mishra, S., Grace, D., Rogers, T., Bayoumi, A. M., et al. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3324-2 · Cited by 38
Reviewing PrEP’s Effect on STI Incidence Among Men Who Have sex with Men—Balancing Increased STI Screening and Potential Behavioral Sexual Risk Compensation
Kumar, S., Haderxhanaj, L. T., & Spicknall, I. H. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-03110-x · Cited by 37
Adherence to Pre-Exposure Prophylaxis in Adolescents and Young Adults: A Systematic Review and Meta-Analysis
Allison, B. A., Widman, L. M., Stewart, J., Evans-Paulson, R., & Perry, M. F. (2021) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2021.04.001 · Cited by 37
Functional Knowledge of Pre-Exposure Prophylaxis for HIV Prevention Among Participants in a Web-Based Survey of Sexually Active Gay, Bisexual, and Other Men Who Have Sex With Men: Cross-Sectional Study
Kahle, E., Sullivan, S. P., & Stephenson, R. B. (2018) · JMIR Public Health and Surveillance · doi:10.2196/publichealth.8089 · Cited by 36
Trajectories and Predictors of Longitudinal Preexposure Prophylaxis Adherence Among Men Who Have Sex With Men
Pasipanodya, E. C., Jain, S., Sun, X., Blumenthal, J. S., Ellorin, E. E., Corado, K., Dubé, M. P., Daar, E. S., Morris, S., Moore, D. J., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy368 · Cited by 36
We need to consider collateral damage to resistomes when we decide how frequently to screen for chlamydia/gonorrhoea in preexposure prophylaxis cohorts
Kenyon, C. R. (2018) · AIDS · doi:10.1097/qad.0000000000002020 · Cited by 34
Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants
Meyers, K. A., Rodriguez, K., Brill, A. L., Wu, Y., Mar, M. L., Dunbar, D., Koblin, B. A., Margolis, D. M., Sobieszczyk, M. E., Tieu, H., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1871-x · Cited by 35
PrEP Continuation, HIV and STI Testing Rates, and Delivery of Preventive Care in a Clinic-Based Cohort
Hevey, M. A., Walsh, J. L., & Petroll, A. E. (2018) · AIDS Education and Prevention · doi:10.1521/aeap.2018.30.5.393 · Cited by 36
Factors Associated With Sex-Related Pre-exposure Prophylaxis Adherence Among Men Who Have Sex With Men in New York City in HPTN 067
Mannheimer, S., Hirsch‐Moverman, Y., Franks, J. C., Loquere, A., Hughes, J. P., Li, M., Amico, K. R., & Grant, R. M. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001965 · Cited by 36
Advancing the HIV Pre-Exposure Prophylaxis Continuum: A Collaboration Between a Public Health Department and a Federally Qualified Health Center in the Southern United States
Clement, M. E., Johnston, B. E., Eagle, C., Taylor, D., Rosengren, A. L., Goldstein, B. A., & Seña, A. C. (2019) · AIDS Patient Care and STDs · doi:10.1089/apc.2019.0054 · Cited by 35
Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model
Maloney, K. M., Guillou, A. L., Driggers, R. A., Sarkar, S., Anderson, E. J., Malik, A. A., & Jenness, S. M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa552 · Cited by 35
A Scoping Review Investigating Relationships between Depression, Anxiety, and the PrEP Care Continuum in the United States
Miller, S. J., Harrison, S. E., & Sanasi-Bhola, K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111431 · Cited by 37
Population‐level impact of expanding PrEP coverage by offering long‐acting injectable PrEP to MSM in three high‐resource settings: a model comparison analysis
Stansfield, S. E., Heitner, J., Mitchell, K. M., Doyle, C. M., Milwid, R. M., Moore, M., Donnell, D. J., Hanscom, B. S., Xia, Y., Maheu‐Giroux, M., et al. (2023) · Journal of the International AIDS Society · doi:10.1002/jia2.26109 · Cited by 34
Reaching Key Populations: PrEP Uptake in an Urban Health Care System in the Bronx, New York
Bien, C. H., Patel, V. V., Blackstock, O. J., & Felsen, U. R. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1663-8 · Cited by 34
A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study
Saberi, P., Berrean, B., Thomas, S., Gandhi, M., & Scott, H. M. (2018) · JMIR Formative Research · doi:10.2196/formative.8623 · Cited by 34
Potential Impact of HIV Preexposure Prophylaxis Among Black and White Adolescent Sexual Minority Males
Hamilton, D. T., Goodreau, S. M., Jenness, S. M., Sullivan, P. S., Wang, L. Y., Dunville, R. L., Barrios, L. C., & Rosenberg, E. S. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304471 · Cited by 34

Authors: Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., Liegler, T., Rawlings, M. K., Trainor, N., Blue, R. W., Estrada, Y., Coleman, M. E., Cardenas, G., Feaster, D. J., Grant, R., Philip, S. S., Elion, R., Buchbinder, S., & Kolber, M. A.
Affiliations: University of California, San Francisco (US)
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora
Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida
National Institutes of Health (US)
DF/Net Research, Inc, Seattle, Washington
San Francisco Department of Public Health (US)
University of Michigan (US)
Gilead Sciences (United States) (US)
University of Miami (US)
Whitman-Walker Health (US)
Gladstone Institutes (US)
George Washington University (US)
Corresponding author: Liu, Albert Y.
ORCID: Liu, Albert Y.
Cohen, Stephanie E.
Vittinghoff, Eric
Anderson, Peter L.
Bacon, Oliver
Chege, Wairimu
Matheson, Tim
Amico, K. Rivet
Rawlings, M. Keith
Estrada, Yannine
Coleman, Megan E.
Feaster, Daniel J.
Grant, Robert
Philip, Susan S.
Buchbinder, Susan
Kolber, Michael A.
Venue: JAMA Internal Medicine
Publisher: American Medical Association (AMA)
Published: 2016-01-01
Volume: 176
Issue: 1
Pages: 75
ISSN: 2168-6106 (ISSN-L)
DOI: 10.1001/jamainternmed.2015.4683
PMC: PMC5042323
OpenAlex: W2173821673
Cited by: 602
References: 46
Citations by year: 2026: 12 · 2025: 29 · 2024: 42 · 2023: 45 · 2022: 57 · 2021: 47 · 2020: 68 · 2019: 87 · 2018: 83 · 2017: 71 · 2016: 57
FWCI: 55.55
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: JAMA Internal Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institutes of Health
National Institute of Mental Health (R01MH095628)
National Institute of Allergy and Infectious Diseases (R01AI118575, UM1AI069496, P30AI027763, P30AI073961)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: pre-exposure prophylaxis, HIV prevention, men who have sex with men, transgender women, tenofovir disoproxil fumarate, emtricitabine, PrEP adherence, sexually transmitted infections, sexual partners, HIV acquisition, HIV testing, community health centers, STD clinics, housing stability
MeSH terms: Tenofovir, Assessment of Medication Adherence, Adenine, Adolescent, Adult, Bisexuality, Chlamydia Infections, Community Health Services, District of Columbia, Female, Florida, Gonorrhea, Humans, Male, Middle Aged, Organophosphates, Prospective Studies, San Francisco, Sexual Behavior, Syphilis, HIV Infections, Drug Monitoring, Homosexuality, Male, Anti-HIV Agents, Unsafe Sex, Medication Adherence, Young Adult, Reproductive Health, Transgender Persons, Pre-Exposure Prophylaxis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks